サマリー

プレガバリンの世界市場 2022-2026 年
Technavioはプレガバリン市場を監視しており、2022-2026年の間に1億5303万ドルの成長が見込まれ、予測期間中にCAGR 3.74%で加速しています。当レポートでは、プレガバリン市場の全体分析、市場規模・予測、トレンド、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、神経障害性疼痛に関連する大規模な患者プールの存在、老年人口の増加、および様々な疾患におけるプレガバリンの用途の増加によって牽引されています。
プレガバリン市場の分析には、用途別セグメントと地理的展望が含まれます。
Technavioのプレガバリン市場は、以下のようにセグメント化されています。
アプリケーション別
- 神経障害性疼痛
- てんかん
- 不安障害
- その他
地域別構成比
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間におけるプレガバリン市場の成長を促進する主な理由の一つとして、新興国への注目の高まりを挙げています。また、糖尿病やHIVの発症率の増加や医療費の増加が、市場の大きな需要につながると考えられます。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。プレガバリン市場に関する当レポートの対象領域は次のとおりです。
- プレガバリン市場のサイジング
- プレガバリン市場の予測
- プレガバリン市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、Biomax Biotechnics Pvt. Ltd., Camber Pharmaceuticals Inc., Cipla Ltd., Dr. Kumars Pharmaceuticals, Genesis Biotec Inc,H. L. Healthcare Pvt. Ltd.、Lupin Ltd.、Medley Pharmaceuticals Ltd.、MK Medicine、MSN Laboratories、Neuracle Lifesciences Pvt. Ltd.、Novartis AG、Pfizer Inc. Phoenix Biologicals Pvt. Ltd., Sun Pharmaceutical Industries Ltd, Swastik Life Sciences, Torrent Pharmaceuticals Ltd. and Vibcare Pharma Pvt. Ltd.(以下「SF社」)。また、プレガバリン市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、以下をご覧ください - [https://www.technavio.com/report/pregabalin-market-industry-analysis](https://www.technavio.com/report/pregabalin-market-industry-analysisv)
Technavio社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法によって、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Application
o 5.1 Market segments
o Exhibit 24: Chart on Application - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
o 5.2 Comparison by Application
o Exhibit 26: Chart on Comparison by Application
o Exhibit 27: Data Table on Comparison by Application
o 5.3 Neuropathic pain - Market size and forecast 2021-2026
o Exhibit 28: Chart on Neuropathic pain - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Neuropathic pain - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Neuropathic pain - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Neuropathic pain - Year-over-year growth 2021-2026 (%)
o 5.4 Epilepsy - Market size and forecast 2021-2026
o Exhibit 32: Chart on Epilepsy - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Epilepsy - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Epilepsy - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Epilepsy - Year-over-year growth 2021-2026 (%)
o 5.5 Anxiety disorders - Market size and forecast 2021-2026
o Exhibit 36: Chart on Anxiety disorders - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Anxiety disorders - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Anxiety disorders - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Anxiety disorders - Year-over-year growth 2021-2026 (%)
o 5.6 Others - Market size and forecast 2021-2026
o Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by Application
o Exhibit 44: Market opportunity by Application ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Japan - Market size and forecast 2021-2026
o Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
o 7.12 Republic of Korea - Market size and forecast 2021-2026
o Exhibit 86: Chart on Republic of Korea - Market size and forecast 2021-2026 ($ million)
o Exhibit 87: Data Table on Republic of Korea - Market size and forecast 2021-2026 ($ million)
o Exhibit 88: Chart on Republic of Korea - Year-over-year growth 2021-2026 (%)
o Exhibit 89: Data Table on Republic of Korea - Year-over-year growth 2021-2026 (%)
o 7.13 Market opportunity By Geographical Landscape
o Exhibit 90: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 91: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 93: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 94: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 95: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 96: Matrix on vendor position and classification
o 10.3 Biomax Biotechnics Pvt. Ltd.
o Exhibit 97: Biomax Biotechnics Pvt. Ltd. - Overview
o Exhibit 98: Biomax Biotechnics Pvt. Ltd. - Product / Service
o Exhibit 99: Biomax Biotechnics Pvt. Ltd. - Key offerings
o 10.4 Camber Pharmaceuticals Inc.
o Exhibit 100: Camber Pharmaceuticals Inc. - Overview
o Exhibit 101: Camber Pharmaceuticals Inc. - Product / Service
o Exhibit 102: Camber Pharmaceuticals Inc. - Key offerings
o 10.5 Cipla Ltd.
o Exhibit 103: Cipla Ltd. - Overview
o Exhibit 104: Cipla Ltd. - Business segments
o Exhibit 105: Cipla Ltd. - Key news
o Exhibit 106: Cipla Ltd. - Key offerings
o Exhibit 107: Cipla Ltd. - Segment focus
o 10.6 Genesis Biotec Inc.
o Exhibit 108: Genesis Biotec Inc. - Overview
o Exhibit 109: Genesis Biotec Inc. - Product / Service
o Exhibit 110: Genesis Biotec Inc. - Key offerings
o 10.7 Lupin Ltd
o Exhibit 111: Lupin Ltd - Overview
o Exhibit 112: Lupin Ltd - Product / Service
o Exhibit 113: Lupin Ltd - Key news
o Exhibit 114: Lupin Ltd - Key offerings
o 10.8 Medley Pharmaceuticals Ltd.
o Exhibit 115: Medley Pharmaceuticals Ltd. - Overview
o Exhibit 116: Medley Pharmaceuticals Ltd. - Product / Service
o Exhibit 117: Medley Pharmaceuticals Ltd. - Key offerings
o 10.9 MK Medicine
o Exhibit 118: MK Medicine - Overview
o Exhibit 119: MK Medicine - Product / Service
o Exhibit 120: MK Medicine - Key offerings
o 10.10 Novartis AG
o Exhibit 121: Novartis AG - Overview
o Exhibit 122: Novartis AG - Business segments
o Exhibit 123: Novartis AG - Key offerings
o Exhibit 124: Novartis AG - Segment focus
o 10.11 Pfizer Inc.
o Exhibit 125: Pfizer Inc. - Overview
o Exhibit 126: Pfizer Inc. - Product / Service
o Exhibit 127: Pfizer Inc. - Key news
o Exhibit 128: Pfizer Inc. - Key offerings
o 10.12 Torrent Pharmaceuticals Ltd.
o Exhibit 129: Torrent Pharmaceuticals Ltd. - Overview
o Exhibit 130: Torrent Pharmaceuticals Ltd. - Business segments
o Exhibit 131: Torrent Pharmaceuticals Ltd. - Key offerings
o Exhibit 132: Torrent Pharmaceuticals Ltd. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 133: Inclusions checklist
o Exhibit 134: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 135: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 136: Research methodology
o Exhibit 137: Validation techniques employed for market sizing
o Exhibit 138: Information sources
o 11.5 List of abbreviations
o Exhibit 139: List of abbreviations
o Population
o pressure
o in incidence rate


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Application - Market share 2021-2026 (%)
Exhibits25: Data Table on Application - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Application
Exhibits27: Data Table on Comparison by Application
Exhibits28: Chart on Neuropathic pain - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Neuropathic pain - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Neuropathic pain - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Neuropathic pain - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Epilepsy - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Epilepsy - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Epilepsy - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Epilepsy - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Anxiety disorders - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Anxiety disorders - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Anxiety disorders - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Anxiety disorders - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Application ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits86: Chart on Republic of Korea - Market size and forecast 2021-2026 ($ million)
Exhibits87: Data Table on Republic of Korea - Market size and forecast 2021-2026 ($ million)
Exhibits88: Chart on Republic of Korea - Year-over-year growth 2021-2026 (%)
Exhibits89: Data Table on Republic of Korea - Year-over-year growth 2021-2026 (%)
Exhibits90: Market opportunity By Geographical Landscape ($ million)
Exhibits91: Impact of drivers and challenges in 2021 and 2026
Exhibits92: Overview on Criticality of inputs and Factors of differentiation
Exhibits93: Overview on factors of disruption
Exhibits94: Impact of key risks on business
Exhibits95: Vendors covered
Exhibits96: Matrix on vendor position and classification
Exhibits97: Biomax Biotechnics Pvt. Ltd. - Overview
Exhibits98: Biomax Biotechnics Pvt. Ltd. - Product / Service
Exhibits99: Biomax Biotechnics Pvt. Ltd. - Key offerings
Exhibits100: Camber Pharmaceuticals Inc. - Overview
Exhibits101: Camber Pharmaceuticals Inc. - Product / Service
Exhibits102: Camber Pharmaceuticals Inc. - Key offerings
Exhibits103: Cipla Ltd. - Overview
Exhibits104: Cipla Ltd. - Business segments
Exhibits105: Cipla Ltd. - Key news
Exhibits106: Cipla Ltd. - Key offerings
Exhibits107: Cipla Ltd. - Segment focus
Exhibits108: Genesis Biotec Inc. - Overview
Exhibits109: Genesis Biotec Inc. - Product / Service
Exhibits110: Genesis Biotec Inc. - Key offerings
Exhibits111: Lupin Ltd - Overview
Exhibits112: Lupin Ltd - Product / Service
Exhibits113: Lupin Ltd - Key news
Exhibits114: Lupin Ltd - Key offerings
Exhibits115: Medley Pharmaceuticals Ltd. - Overview
Exhibits116: Medley Pharmaceuticals Ltd. - Product / Service
Exhibits117: Medley Pharmaceuticals Ltd. - Key offerings
Exhibits118: MK Medicine - Overview
Exhibits119: MK Medicine - Product / Service
Exhibits120: MK Medicine - Key offerings
Exhibits121: Novartis AG - Overview
Exhibits122: Novartis AG - Business segments
Exhibits123: Novartis AG - Key offerings
Exhibits124: Novartis AG - Segment focus
Exhibits125: Pfizer Inc. - Overview
Exhibits126: Pfizer Inc. - Product / Service
Exhibits127: Pfizer Inc. - Key news
Exhibits128: Pfizer Inc. - Key offerings
Exhibits129: Torrent Pharmaceuticals Ltd. - Overview
Exhibits130: Torrent Pharmaceuticals Ltd. - Business segments
Exhibits131: Torrent Pharmaceuticals Ltd. - Key offerings
Exhibits132: Torrent Pharmaceuticals Ltd. - Segment focus
Exhibits133: Inclusions checklist
Exhibits134: Exclusions checklist
Exhibits135: Currency conversion rates for US$
Exhibits136: Research methodology
Exhibits137: Validation techniques employed for market sizing
Exhibits138: Information sources
Exhibits139: List of abbreviations